STAAB THOMAS R II

Senior Vice President and CFO at BIOCRYST PHARMACEUTICALS INC · on record since Jul 8, 2011
Chief Financial Officer at LENSAR, Inc. · on record since May 8, 2026
Chief Financial Officer at TENAX THERAPEUTICS, INC. · on record since May 13, 2026
CFO & Treasurer at INSPIRE PHARMACEUTICALS INC · on record since Jul 14, 2005

Insider trading activity of STAAB THOMAS R II

Transactions on record: 285; since Oct 17, 2003

Open-market buys: 3; $19.7K

Open-market sells: 56; $2.4M

Companies traded: 4; last filing Sep 15, 2026

Figures computed from official regulatory filings — .

Companies where STAAB THOMAS R II has traded

TENAX THERAPEUTICS, INC.3 tx · $11K · Sep 15, 2026
LENSAR, Inc.19 tx · $96.5K · May 8, 2026
BIOCRYST PHARMACEUTICALS INC203 tx · $4.5M · Feb 25, 2020
INSPIRE PHARMACEUTICALS INC60 tx · $120.5K · May 16, 2011

Track record of STAAB THOMAS R II

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of STAAB THOMAS R II

Co-insiders of STAAB THOMAS R II

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
TENAX THERAPEUTICS, INC.Listing on record	Sep 15, 2026	Buy	5,675	1.94 USD	$11K	conv 89ClusterFirst in 12mo	SEC
TENAX THERAPEUTICS, INC.Listing on record	May 13, 2026	AwardD (derivative)	450,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TENAX THERAPEUTICS, INC.Listing on record	May 13, 2026	Award	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	May 8, 2026	Other	-1,350	5.39 USD	$7.3K		SEC
LENSAR, Inc.Listing on record	Mar 19, 2026	ExerciseD (derivative)	-5,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Mar 19, 2026	Exercise	5,500	2.65 USD	$14.6K		SEC
LENSAR, Inc.Listing on record	Feb 20, 2026	Other	-1,076	11.32 USD	$12.2K		SEC
LENSAR, Inc.Listing on record	Jan 13, 2026	Other	-1,826	11.57 USD	$21.1K		SEC
LENSAR, Inc.Listing on record	Feb 20, 2025	Award	12,766	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Feb 6, 2025	Other	-1,839	8.25 USD	$15.2K		SEC
LENSAR, Inc.Listing on record	Aug 12, 2024	ExerciseD (derivative)	-3,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Aug 12, 2024	Exercise	3,500	2.65 USD	$9.3K		SEC
LENSAR, Inc.Listing on record	May 8, 2024	Other	-1,853	4.43 USD	$8.2K		SEC
LENSAR, Inc.Listing on record	May 8, 2024	Award	19,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Jan 13, 2023	Award	6,656	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Jan 13, 2023	AwardD (derivative)	23,295	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Dec 7, 2022	Buy	727	3.16 USD	$2.3K	conv 46	SEC
LENSAR, Inc.Listing on record	Dec 7, 2022	Buy	2,025	3.16 USD	$6.4K	conv 64First in 12mo	SEC
LENSAR, Inc.Listing on record	Jan 13, 2022	Award	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Jan 13, 2022	AwardD (derivative)	52,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Apr 14, 2021	AwardD (derivative)	49,197	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Dec 10, 2020	Award	19,276	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Feb 25, 2020	AwardD (derivative)	18,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Feb 19, 2020	AwardD (derivative)	31,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Dec 26, 2019	AwardD (derivative)	127,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
TENAX THERAPEUTICS, INC.Listing on record	Sep 15, 2026	Buy	5,675	1.94 USD	$11K	conv 89ClusterFirst in 12mo	SEC
TENAX THERAPEUTICS, INC.Listing on record	May 13, 2026	AwardD (derivative)	450,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TENAX THERAPEUTICS, INC.Listing on record	May 13, 2026	Award	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	May 8, 2026	Other	-1,350	5.39 USD	$7.3K		SEC
LENSAR, Inc.Listing on record	Mar 19, 2026	ExerciseD (derivative)	-5,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Mar 19, 2026	Exercise	5,500	2.65 USD	$14.6K		SEC
LENSAR, Inc.Listing on record	Feb 20, 2026	Other	-1,076	11.32 USD	$12.2K		SEC
LENSAR, Inc.Listing on record	Jan 13, 2026	Other	-1,826	11.57 USD	$21.1K		SEC
LENSAR, Inc.Listing on record	Feb 20, 2025	Award	12,766	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Feb 6, 2025	Other	-1,839	8.25 USD	$15.2K		SEC
LENSAR, Inc.Listing on record	Aug 12, 2024	ExerciseD (derivative)	-3,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Aug 12, 2024	Exercise	3,500	2.65 USD	$9.3K		SEC
LENSAR, Inc.Listing on record	May 8, 2024	Other	-1,853	4.43 USD	$8.2K		SEC
LENSAR, Inc.Listing on record	May 8, 2024	Award	19,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Jan 13, 2023	Award	6,656	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Jan 13, 2023	AwardD (derivative)	23,295	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Dec 7, 2022	Buy	727	3.16 USD	$2.3K	conv 46	SEC
LENSAR, Inc.Listing on record	Dec 7, 2022	Buy	2,025	3.16 USD	$6.4K	conv 64First in 12mo	SEC
LENSAR, Inc.Listing on record	Jan 13, 2022	Award	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Jan 13, 2022	AwardD (derivative)	52,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Apr 14, 2021	AwardD (derivative)	49,197	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LENSAR, Inc.Listing on record	Dec 10, 2020	Award	19,276	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Feb 25, 2020	AwardD (derivative)	18,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Feb 19, 2020	AwardD (derivative)	31,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Dec 26, 2019	AwardD (derivative)	127,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC